# Hetero Drugs Ltd. - Unit 1 - Inspection Records

Source: https://www.keypedia.com/companies/hetero-drugs-ltd-unit-1/4c15935a-9ff7-4f66-b649-3d78aa3e9753

> Inspection records and compliance data for Hetero Drugs Ltd. - Unit 1 in Telangana, None. Access full analysis and detailed observations.

---

## Details

- Name: Hetero Drugs Ltd. - Unit 1
- FEI Number: 3003510514
- City: Telangana
- State: None
- Country Name: India
- Address Line 1: Plot Nos. 213
- Address Line 2: 214, 255, Bonthapally Village, Gummadidala Mandal, Sangareddy
- Zip Code: None
- Facility Type: Active Pharmaceutical Ingredients Manufacturer
- Business Operations: API MANUFACTURE

## Related Documents

- [483 - Hetero Drugs Ltd. - Unit 1 - Unknown Date](https://www.keypedia.com/records/483/hetero-drugs-ltd-unit-1/2f5e8642-953a-44f2-b954-3649b3a9f37d) — source: FDA, date: Invalid Date
- [483 - Hetero Drugs Ltd. - Unit 1 - 2025-05-16](https://www.keypedia.com/records/483/hetero-drugs-ltd-unit-1/380fe241-c7a9-4330-bbe5-26066c4980b8) — source: FDA, date: May 16, 2025
- [FDA Inspection 1269555 - Hetero Drugs Ltd. - Unit 1 - 2025-05-16](https://www.keypedia.com/records/fda_inspections/hetero-drugs-ltd-unit-1/728fbd7f-8fcd-4259-b230-c3f8aa5ede35) — source: FDA, date: May 16, 2025
- [FDA Inspection 1269555 - Hetero Drugs Ltd. - Unit 1 - 2025-05-16](https://www.keypedia.com/records/fda_inspections/hetero-drugs-ltd-unit-1/f7fb4c9e-1292-47b2-8919-9d196ee192e3) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 16, 2025
- [EIR - Hetero Drugs Ltd. - Unit 1 - 2020-02-14](https://www.keypedia.com/records/eir/hetero-drugs-ltd-unit-1/f2d0cfb9-2f77-4c33-b458-bfeb465a8c6b) — source: FDA, date: February 14, 2020
- [FDA Inspection 1121294 - Hetero Drugs Ltd. - Unit 1 - 2020-02-14](https://www.keypedia.com/records/fda_inspections/hetero-drugs-ltd-unit-1/dded6acb-2152-4423-970f-d23e96cff3cf) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 14, 2020
- [483 - Hetero Drugs Ltd. - Unit 1 - 2018-03-02](https://www.keypedia.com/records/483/hetero-drugs-ltd-unit-1/f6db977b-5b72-4d7e-80c4-216e53e6c01d) — source: FDA, date: March 2, 2018
- [FDA Inspection 1044698 - Hetero Drugs Ltd. - Unit 1 - 2018-03-02](https://www.keypedia.com/records/fda_inspections/hetero-drugs-ltd-unit-1/75379504-1534-4c90-a4f5-60c8f64105c9) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 2, 2018
- [FDA Inspection 963050 - Hetero Drugs Ltd. - Unit 1 - 2016-02-25](https://www.keypedia.com/records/fda_inspections/hetero-drugs-ltd-unit-1/da490c83-d41b-4116-a50a-bf9494179cfa) — classification: No Action Indicated (NAI), source: FDA, date: February 25, 2016
- [FDA Inspection 888747 - Hetero Drugs Ltd. - Unit 1 - 2014-05-02](https://www.keypedia.com/records/fda_inspections/hetero-drugs-ltd-unit-1/d87f37c9-d2fa-4a24-aa5f-a5db6a7d2e40) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 2, 2014
- [FDA Inspection 700761 - Hetero Drugs Ltd. - Unit 1 - 2010-11-11](https://www.keypedia.com/records/fda_inspections/hetero-drugs-ltd-unit-1/38485c2a-930b-4595-9cdb-a178158c765f) — classification: No Action Indicated (NAI), source: FDA, date: November 11, 2010

## Related Companies

- [Chunghwa Chemical Synthesis & Biotech Co., Ltd](https://www.keypedia.com/companies/chunghwa-chemical-synthesis-biotech-co-ltd/4c8ab291-0275-4884-960a-f5b3bc604eff)
- [US Specialty Formulations LLC](https://www.keypedia.com/companies/us-specialty-formulations-llc/2a5dd57a-6a0b-44a4-88ec-d642f91d1315)
- [Novo Nordisk US Bio Production Inc.](https://www.keypedia.com/companies/novo-nordisk-us-bio-production-inc/08f5214b-4db0-4d94-86ee-4ba9c3c28ea2)
- [BASF SE](https://www.keypedia.com/companies/basf-se/96b65069-a37b-4a26-9655-5f310b60cc6f)
- [Kumar Organic Products Ltd.](https://www.keypedia.com/companies/kumar-organic-products-ltd/acc61a81-a684-4eb3-a4c8-d487dc0164e5)
- [Sri Krishna Pharmaceuticals Limited](https://www.keypedia.com/companies/sri-krishna-pharmaceuticals-limited/5afbb0e4-2595-4bfc-8ecd-7c0d9deb8b38)
- [PharmaZell GmbH](https://www.keypedia.com/companies/pharmazell-gmbh/37149959-807d-41b5-be90-cc07ca5a6098)
- [Sichuan Qingmu Pharmaceutical Co., Ltd](https://www.keypedia.com/companies/sichuan-qingmu-pharmaceutical-co-ltd/821a1489-2969-47a3-8321-b97728ac795a)
- [Dasami Lab Private Limited](https://www.keypedia.com/companies/dasami-lab-private-limited/950d9812-d647-4e9e-ad9a-01eab0ebe091)
- [Sri Krishna Pharmaceuticals Limited - Unit IV](https://www.keypedia.com/companies/sri-krishna-pharmaceuticals-limited-unit-iv/fd405e8b-b747-4adb-bbb5-da63c0cfa56b)

## Related Officers

- [Yvins Dezan](https://www.keypedia.com/people/yvins-dezan/e9fd12e6-c090-4eb6-bc78-8b80e8a90946)
- [recipient](https://www.keypedia.com/people/sambi-reddy-jonnala/42250544-c5fb-405f-b7b1-b113b607cd86)
- [issuing_officer](https://www.keypedia.com/people/valerie-l-whipp/70c97f44-c351-499b-afd3-166b4330ae52)
- [investigator](https://www.keypedia.com/people/michael-l-casner/a0f35f37-4795-4edf-a9f6-a447d64c0fd4)
- [Sneha Patel](https://www.keypedia.com/people/sneha-patel/b7425bea-67ce-4c9b-af5a-51515bdd9f2e)